You are here: All Products  > GSK Launches Triple-Therapy HIV Drug in China at a Low-Cost $450/Month

GSK Launches Triple-Therapy HIV Drug in China at a Low-Cost $450/Month

Price: $5.00
Available
Get instant access to this article for unlimited viewing and/or downloading for seven days.

Back to products